India’s healthcare sector saw major funding, partnerships, investments, expansion plans, and pharma developments this week. KKR moved to acquire Medicover India in a USD 1.5 billion healthcare deal. Cipla and Rocket India announced...
Clinical innovation drives a new wave of transformation as companies expand biosimilars portfolios, regulators strengthen drug quality frameworks
Medical device manufacturing in India is set to enter a new shift as the government strengthens its push to build an export-oriented ecosystem
Skin cancer continues to challenge global healthcare systems as cases rise and treatment gaps persist. But a recent USFDA approval has introduced new hope in skin cancer treatment
Global health concern intensifies as the latest Salmonella outbreak in the United States exposes the growing risks linked to foodborne infections
Drug research in India is undergoing a major shift as the government accelerates support for non-animal testing methods
Ebola outbreak conditions worsen in Congo as confirmed infections cross 4,000, marked as one of the most severe health emergencies
Pharma regulation reform, cancer care access, and drug safety drive the latest developments in the pharmaceutical sector, as policymakers and companies have accelerated structural changes and healthcare outreach
The Semaglutide patent stands at the center of a major Novo Nordisk legal case as the company strengthens pharma patent enforcement across Europe
Pharma companies in India face a stricter test as the Centre amends the Drugs Rules to debar companies that submit fake or fabricated data during drug approval applications
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")